Two updated Cochrane reviews and one new protocol are available in Issue 1, 2021 of the Cochrane Database of Systematic Reviews.

New Cochrane Protocol

Weeratunga  P, Bancone  G, Ochodo  EA, Pant  S, Thapa  J, Chaplin  M. Glucose‐6‐phosphate dehydrogenase deficiency near‐patient tests for tafenoquine or primaquine use with Plasmodium vivax malaria. Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No.: CD013861. DOI: 10.1002/14651858.CD013861. 

Updated Cochrane Reviews 

Ejemot-Nwadiaro RI, Ehiri JE, Arikpo D, Meremikwu MM, Critchley JA. Hand‐washing promotion for preventing diarrhoea. Cochrane Database of Systematic Reviews 2020, Issue 12. Art. No.: CD004265. DOI: 10.1002/14651858.CD004265.pub4.

Blanshard  A, Hine  P. Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No.: CD004529. DOI: 10.1002/14651858.CD004529.pub3.  

Kohli  M, Schiller  I, Dendukuri  N, Yao  M, Dheda  K, Denkinger  CM, Schumacher  SG, Steingart  KR. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No.: CD012768. DOI: 10.1002/14651858.CD012768.pub3.  

The CIDG editorial base is located at the Liverpool School of Tropical Medicine  in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. 

The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the  United Nations Sustainable Development Goals